If you have any question, please feel free to email us. We will touch with you as soon as possible.
Brexpiprazole is a serotonin-dopamine activity modulator (SDAM) that acts as a partial agonist at 5-HT1A and dopamine D2 receptors, and an antagonist at 5-HT2A and noradrenaline alpha1B/2C receptors. It received manufacturing and marketing approval in Japan for the indication of schizophrenia in 2018. For R&D purposes only.
* Please be kindly noted products are not for therapeutic use. We do not sell to patients.
| Drug Generic Name | 布瑞哌唑口崩片 |
|---|---|
| Trade Name | Brexpiprazole Orally Disintegrating Tablets |
| Brand Name | Rexulti®OD Tablets |
| Dosage Form | Tablets |
| Strength | 0.5mg |
| Holder | Otsuka Pharmaceutical Co., Ltd. |
| Remarks | Japan listing |
| Product Type | Reference Listed Drugs (RLDs) |
Brexpiprazole is a serotonin-dopamine activity modulator (SDAM) that acts as a partial agonist at 5-HT1A and dopamine D2 receptors, and an antagonist at 5-HT2A and noradrenaline alpha1B/2C receptors. It received manufacturing and marketing approval in Japan for the indication of schizophrenia in 2018.
Looking for more information and services? Get in touch with us today!
Email: tosun-global@upharm.cn
Wechat/WhatsApp: (+86)189-2212-0575
Hot Tags: Brexpiprazole Orally Disintegrating Tablets Reference Listed Drug, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Alfacalcidol Soft Capsules, Agomelatine Tablets, Reference Listed Drugs, Bimatoprost Ophthalmic, Acarbose Tablets, AdapaleneGel
Tel:+86-020-61855200-902
Fax:+86-020-66392525
Email:info@upharm.cn
Address:12th floor, No. 181, Kexue Avenue, Huangpu District, Guangzhou, China
